Related references
Note: Only part of the references are listed.EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction
Matthias Oelke et al.
EUROPEAN UROLOGY (2013)
Noradrenaline induces binding of Clathrin light chain A to α1-adrenoceptors in the human prostate
Martin Hennenberg et al.
PROSTATE (2013)
Small Interfering RNA Transfection Against Serum Response Factor Mediates Growth Inhibition of Benign Prostatic Hyperplasia Fibroblasts
Andrea Nolte et al.
NUCLEIC ACID THERAPEUTICS (2013)
Phenotype pharmacology of lower urinary tract α1-adrenoceptors
A. Nishimune et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
What makes the α1A-adrenoceptor gene express the α1L-adrenoceptor functional phenotype?
S. Ventura
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Inhibition of adrenergic human prostate smooth muscle contraction by the inhibitors of c-Jun N-terminal kinase, SP600125 and BI-78D3
F. Strittmatter et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Silodosin: a new subtype selective alpha-1 antagonist for the treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasia
Nadir I. Osman et al.
EXPERT OPINION ON PHARMACOTHERAPY (2012)
Activation of protein kinase B/Akt by alpha1-adrenoceptors in the human prostate
Frank Strittmatter et al.
LIFE SCIENCES (2012)
Silodosin Inhibits Noradrenaline-Activated Transcription Factors Elk1 and SRF in Human Prostate Smooth Muscle
Martin Hennenberg et al.
PLOS ONE (2012)
Expression and Alpha1-adrenoceptor Regulation of Caldesmon in Human Prostate Smooth Muscle
Sebastian Walther et al.
UROLOGY (2012)
Correlation between expression of α1-adrenoceptor subtype mRNA and severity of lower urinary tract symptoms or bladder outlet obstruction in benign prostatic hyperplasia patients
Yoshiyuki Kojima et al.
BJU INTERNATIONAL (2011)
Thromboxane A2 induces contraction of human prostate smooth muscle by Rho kinase- and calmodulin-dependent mechanisms
Frank Strittmatter et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Silodosin Therapy for Lower Urinary Tract Symptoms in Men with Suspected Benign Prostatic Hyperplasia: Results of an International, Randomized, Double-Blind, Placebo- and Active-Controlled Clinical Trial Performed in Europe
Christopher R. Chapple et al.
EUROPEAN UROLOGY (2011)
Up-Regulation of α1a and α1d-Adrenoceptors in the Prostate by Administration of Subtype Selective α1-Adrenoceptor Antagonist Tamsulosin in Patients With Benign Prostatic Hyperplasia
Yoshiyuki Kojima et al.
JOURNAL OF UROLOGY (2011)
Emerging paradigms of β-arrestin-dependent seven transmembrane receptor signaling
Arun K. Shukla et al.
TRENDS IN BIOCHEMICAL SCIENCES (2011)
Therapeutic potential of β-arrestin- and G protein-biased agonists
Erin J. Whalen et al.
TRENDS IN MOLECULAR MEDICINE (2011)
β-arrestin-mediated receptor trafficking and signal transduction
Sudha K. Shenoy et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
Coupling of alpha(1)-Adrenoceptors to ERK1/2 in the Human Prostate
Ricarda M. Bauer et al.
UROLOGIA INTERNATIONALIS (2011)
Alpha1-adrenoceptor Signaling in the Human Prostate Involves Regulation of p38 Mitogen-activated Protein Kinase
Frank Strittmatter et al.
UROLOGY (2011)
Beta-arrestin-2 is expressed in human prostate smooth muscle and a binding partner of α1A-adrenoceptors
Martin Hennenberg et al.
WORLD JOURNAL OF UROLOGY (2011)
The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-Year Results from the CombAT Study
Claus G. Roehrborn et al.
EUROPEAN UROLOGY (2010)
Dehydroepiandrosterone-induced proliferation of prostatic epithelial cell is mediated by NFKB via PI3K/AKT signaling pathway
Hong-Zhi Sun et al.
JOURNAL OF ENDOCRINOLOGY (2010)
The Forefront for Novel Therapeutic Agents Based on the Pathophysiology of Lower Urinary Tract Dysfunction: α-Blockers in the Treatment of Male Voiding Dysfunction - How Do They Work and Why Do They Differ in Tolerability?
Martin C. Michel
JOURNAL OF PHARMACOLOGICAL SCIENCES (2010)
Identification of Cysteine-Rich Epidermal Growth Factor-Like Domain 1α (CRELD1α) as a Novel α1A-Adrenoceptor-Down-Regulating Protein and Establishment of an α1L-Adrenoceptor-Expressing Cell Line
Atsushi Nishimune et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2010)
The Modulation of Vascular ATP-Sensitive K+ Channel Function via the Phosphatidylinositol 3-Kinase-Akt Pathway Activated by Phenylephrine
Masanori Haba et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Phosphorylation of Bcl-2 and activation of caspase-3 via the c-Jun N-terminal kinase pathway in ursolic acid-induced DU145 cells apoptosis
Yu-xi Zhang et al.
BIOCHIMIE (2009)
The novel molecule 2-[5-(2-chloroethyl)-2-acetoxy-benzyl]-4-(2-chloroethyl)-phenyl acetate inhibits phosphoinositide 3-kinase/Akt/mammalian target of rapamycin signalling through JNK activation in cancer cells
Ka-Kei Ho et al.
FEBS JOURNAL (2009)
Potential for control of detrusor smooth muscle spontaneous rhythmic contraction by cyclooxygenase products released by interstitial cells of Cajal
Clinton Collins et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Ten commercial antibodies for alpha-1-adrenergic receptor subtypes are nonspecific
Brian C. Jensen et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2009)
Inhibition of human prostate cancer cells proliferation by a selective alpha1-adrenoceptor antagonist labedipinedilol-A involves cell cycle arrest and apoptosis
Shu-Fen Liou et al.
TOXICOLOGY (2009)
Effect of long-term partial bladder outlet obstruction on caldesmon isoforms and their correlation with contractile function
Lin Yang et al.
ACTA PHARMACOLOGICA SINICA (2008)
The α1L-adrenoceptor is an alternative phenotype of the α1A-adrenoceptor
C. P. Nelson
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Native profiles of α1A-adrenoceptor phenotypes in rabbit prostate
T-H Su et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
The α1A-adrenoceptor gene is required for the α1L-adrenoceptor-mediated response in isolated preparations of the mouse prostate
K. T. Gray et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Identification of α1L-adrenoceptor in mice and its abolition by α1A-adrenoceptor gene knockout
I. Muramatsu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Lower urinary tract symptoms revisited: A broader clinical perspective
Christopher R. Chapple et al.
EUROPEAN UROLOGY (2008)
alpha(1)-adrenoceptor subtypes and lower urinary tract symptoms
Debra A. Schwinn et al.
INTERNATIONAL JOURNAL OF UROLOGY (2008)
Smooth muscle signalling pathways in health and disease
H. R. Kim et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Expression of α1-adrenoceptor subtype mRNA as a predictor of the efficacy of subtype selective α1-adrenoceptor antagonists in the management of benign prostatic hyperplasia
Yoshiyuki Kojima et al.
JOURNAL OF UROLOGY (2008)
Terazosin therapy for patients with female lower urinary tract symptoms: A randomized, double-blind, placebo controlled trial
Bee Yean Low et al.
JOURNAL OF UROLOGY (2008)
Do alpha(1)-adrenoceptor antagonists improve lower urinary tract symptoms by reducing bladder outlet resistance?
Maurits M. Barendrecht et al.
NEUROUROLOGY AND URODYNAMICS (2008)
Silibinin Impairs Constitutively Active TGF alpha-EGFR Autocrine Loop in Advanced Human Prostate Carcinoma Cells
Alpna Tyagi et al.
PHARMACEUTICAL RESEARCH (2008)
Thromboxane A(2): Physiology/pathophysiology, cellular signal transduction and pharmacology
Norimichi Nakahata
PHARMACOLOGY & THERAPEUTICS (2008)
The proliferative effect of estradiol on human prostate stromal cells is mediated through activation of ERK
Zhisong Zhang et al.
PROSTATE (2008)
Intracellular Signaling by Akt: Bound to Be Specific
Thomas F. Franke
SCIENCE SIGNALING (2008)
β-Arrestin-biased Agonism at the β2-Adrenergic Receptor
Matthew T. Drake et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Caldesmon is necessary for maintaining the actin and intermediate filaments in cultured bladder smooth muscle cells
Maoxian Deng et al.
CELL MOTILITY AND THE CYTOSKELETON (2007)
Apoptosis induced by capsaicin in prostate PC-3 cells involves ceramide accumulation, neutral sphingomyelinase, and JNK activation
Ana Maria Sanchez et al.
APOPTOSIS (2007)
PARP-1 activation in the ERK signaling pathway
Malka Cohen-Armon
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
A unique mechanism of β-blocker action:: Carvedilol stimulates β-arrestin signaling
James W. Wisler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Change of expression levels of alpha1-adrenoceptor subtypes by administration of alpha1d-adrenoceptor-subtype-selective antagonist naftopidil in benign prostate hyperplasia patients
Yoshiyuki Kojima et al.
PROSTATE (2007)
Mechanisms of induction of airway smooth muscle hyperplasia by transforming growth factor-β
Shaoping Xie et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
Pharmacology of α1-adrenoceptor antagonists in the lower urinary tract and central nervous system
Karl-Erik Andersson et al.
NATURE CLINICAL PRACTICE UROLOGY (2007)
The long-term outcome of medical therapy for BPH
Stephan Madersbacher et al.
EUROPEAN UROLOGY (2007)
Persistent detrusor overactivity after transurethral resection of the prostate is associated with reduced perfusion of the urinary bladder
Michael Mitterberger et al.
BJU INTERNATIONAL (2007)
LUTS treatment: Future treatment options
K.-E. Andersson
NEUROUROLOGY AND URODYNAMICS (2007)
RhoA/Rho kinase-mediated Ca2+ sensitization in the contraction of human prostate
Ryosuke Takahashi et al.
NEUROUROLOGY AND URODYNAMICS (2007)
Rho-kinase and effects of rho-kinase inhibition on the lower urinary tract
George J. Christ et al.
NEUROUROLOGY AND URODYNAMICS (2007)
Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells
Keiko Kawai-Kowase et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
The effect of terazosin on functional bladder outlet obstruction in women: A pilot study
Thomas M. Kessler et al.
JOURNAL OF UROLOGY (2006)
Effect of tamsulosin on spontaneous bladder contraction in conscious rats with bladder outlet obstruction: Comparison with effect on intraurethral pressure
Akiyoshi Ohtake et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Trafficking of G protein-coupled receptors
Matthew T. Drake et al.
CIRCULATION RESEARCH (2006)
Signal switching, crosstalk, and arrestin scaffolds - Novel G protein-coupled receptor signaling in cardiovascular disease
Nicola J. Smith et al.
HYPERTENSION (2006)
Three months' treatment with the α1-blocker alfuzosin does not affect total or transition zone volume of the prostate
C. G. Roehrborn
PROSTATE CANCER AND PROSTATIC DISEASES (2006)
Excitation-transcription coupling in arterial smooth muscle
BR Wamhoff et al.
CIRCULATION RESEARCH (2006)
The p38 transduction pathway in prostatic neoplasia
M Ricote et al.
JOURNAL OF PATHOLOGY (2006)
α1-, α2- and β-adrenoceptors in the urinary bladder, urethra and prostate
MC Michel et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
β-arrestin-dependent, G protein-independent ERK1/2 activation by the β2 adrenergic receptor
SK Shenoy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Excitation-transcription coupling in smooth muscle
CA Barlow et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
Doxazosin induces apoptosis of benign and malignant prostate cells via a death receptor-mediated pathway
JB Garrison et al.
CANCER RESEARCH (2006)
The natural history of lower urinary tract dysfunction in men: Minimum 10-year urodynamic followup of transurethral resection of prostate for bladder outlet obstruction
AW Thomas et al.
JOURNAL OF UROLOGY (2005)
Saposin C stimulates growth and invasion, activates p42/44 and SAPK/JNK signaling pathways of MAPK and upregulates uPA/uPAR expression in prostate cancer and stromal cells
S Koochekpour et al.
ASIAN JOURNAL OF ANDROLOGY (2005)
Recent advances in the protein kinase B signaling pathway
JR Woodgett
CURRENT OPINION IN CELL BIOLOGY (2005)
Regulatory mechanisms of dynamin-dependent endocytosis
K Takei et al.
JOURNAL OF BIOCHEMISTRY (2005)
Mitogen-activated protein kinases in cell-cycle control
RA MacCorkle et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2005)
Phosphorylated 1-caldesmon is involved in disassembly of actin stress fibers and postmitotic spreading
J Kordowska et al.
EXPERIMENTAL CELL RESEARCH (2005)
Response of bladder smooth muscle cells to obstruction: Signal transduction and the role of mechanosensors
O Yamaguchi
UROLOGY (2004)
α1-adrenergic receptors and their inhibitors in lower urinary tract symptoms and benign prostatic hyperplasia
CG Roehrborn et al.
JOURNAL OF UROLOGY (2004)
Reciprocal regulation of angiotensin receptor-activated extracellular signal-regulated kinases by β-arrestins 1 and 2
S Ahn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Enhanced redundancy in Akt and mitogen-activated protein kinase-induced survival of malignant versus normal prostate epithelial cells
AR Uzgare et al.
CANCER RESEARCH (2004)
Effects of α-adrenergic receptor subtype selective antagonists on lower urinary tract function in rats with bladder outlet obstruction
BJ Gu et al.
JOURNAL OF UROLOGY (2004)
Intracellular trafficking of hormone receptors
Z Gáborik et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2004)
Mitogen-activated protein kinase signalling pathways in IL-1β-dependent rat airway smooth muscle proliferation
WW Zhai et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Saw palmetto extract suppresses insulin-like growth factor-I signaling and induces stress-activated protein kinase/c-jun N-terminal kinase phosphorylation in human prostate epithelial cells
TL Wadsworth et al.
ENDOCRINOLOGY (2004)
Molecular regulation of vascular smooth muscle cell differentiation in development and disease
GK Owens et al.
PHYSIOLOGICAL REVIEWS (2004)
Pharmacological and functional characterization of bradykinin B2 receptor in human prostate
D Srinivasan et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Stable interaction between β-arrestin 2 and angiotensin type 1A receptor is required for β-arrestin 2-mediated activation of extracellular signal-regulated kinases 1 and 2
HJ Wei et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Over expression of smooth muscle specific caldesmon by transfection and intermittent agonist induced contraction alters cellular morphology and restores differentiated smooth muscle phenotype
AR Shukla et al.
JOURNAL OF UROLOGY (2004)
The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia
JD McConnell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Ca2+ sensitivity of smooth muscle and nonmuscle myosin II:: Modulated by G proteins, kinases, and myosin phosphatase
AP Somlyo et al.
PHYSIOLOGICAL REVIEWS (2003)
Independent β-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2
HJ Wei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Mitogenic signaling pathways in airway smooth muscle
LM Zhou et al.
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY (2003)
被撤回的出版物: Pharmacological characterization of isolated human prostate (Retracted Article. See vol 170, pg 2394, 2003)
RR Kester et al.
JOURNAL OF UROLOGY (2003)
Norepinephrine activates p44 and p42 MAPK in human prostate stromal and smooth muscle cells but not in epithelial cells
K Kanagawa et al.
PROSTATE (2003)
Ternary complex factors: prime nuclear targets for mitogen-activated protein kinases
PE Shaw et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2003)
Urodynamic effects of alpha-adrenoceptor blockers: A review of clinical trials
BBM Kortmann et al.
UROLOGY (2003)
Arresting angiotensin type 1 receptors
WG Thomas et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2003)
Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis
A Tyagi et al.
ONCOGENE (2003)
The stability of the G protein-coupled receptor-β-arrestin interaction determines the mechanism and functional consequence of ERK activation
A Tohgo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Mechanistic investigation of the adrenergic induction of ventral prostate hyperplasia in mice
D Marinese et al.
PROSTATE (2003)
Regulation of g protein-coupled receptor kinases and arrestins during receptor desensitization
TA Kohout et al.
MOLECULAR PHARMACOLOGY (2003)
Y-27632 a Rho-kinase inhibitor, inhibits proliferation and adrenergic contraction of prostatic smooth muscle cells
RW Rees et al.
JOURNAL OF UROLOGY (2003)
Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases
GL Johnson et al.
SCIENCE (2002)
GR-P receptor-mediated immediate early gene expression and transcription factor Elk-1 activation in prostate cancer cells
DM Xiao et al.
REGULATORY PEPTIDES (2002)
Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice
G Condorelli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
β-arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation
AK Tohgo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Apoptotic and proliferative index after alpha-1-adrenoceptor antagonist and/or finasteride treatment in benign prostatic hyperplasia
T Erdogru et al.
UROLOGIA INTERNATIONALIS (2002)
Review - Induction of prostate apoptosis by alpha(1)-adrenoceptor antagonists: mechanistic significance of the quinazoline component
IE Anglin et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2002)
Signal transduction by G-proteins, Rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II
AP Somlyo et al.
JOURNAL OF PHYSIOLOGY-LONDON (2000)
Share Paper
